Shooting at a moving target: Natural history studies and the rapidly improving state of anti-HIV treatment

Journal of Pediatrics

Volumn 141, Issue 3, 2002, Pages 301-302

  McKinney Jr , Ross E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; EDITORIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

EID: 0036735845     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127274     Document Type: Article

References (6)

1. 2 HIV study
2. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients
3. A trial comparing zidovudine, didanosine, and combination therapy for initial treatment of symptomatic HIV-infected children
4. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naïve HIV-1 infection
5. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1